desmond module (Molecular Dynamics Inc)
86
Structured Review
Molecular Dynamics Inc
desmond module
Desmond Module, supplied by Molecular Dynamics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modul/desmond+module/pm42319587-100-11-0
Average 86 stars, based on 1 article reviews
Desmond Module, supplied by Molecular Dynamics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modul/desmond+module/pm42319587-100-11-0
Average 86 stars, based on 1 article reviews
desmond module - by Bioz Stars,
2026-11
86/100 stars
Images
Related Articles
other:Article Title: Design, semi-synthesis and biological evaluation of grandiflorenic acid derivatives as potent covalent NLRP3 inhibitors. Article Snippet: Targeting the NLRP3 inflammasome has become an attractive therapeutic strategy for a wide range of inflammatory and immune-mediated diseases due to its central role in innate immunity and pathological inflammation.. In this study, a series of novel grandiflorenic acid derivatives were rationally designed and semisynthesized as effective covalent NLRP3 inhibitors.. These compounds inhibited IL-1β release in the nanomolar range, with compound 5 identified as the most potent derivative of the series (IC50 = 1.36 ± 0.21 nM). Article Title: Mindin-mediated αM-integrin endocytosis activates STAT3 to maintain keratinocyte stemness. Article Snippet: Article Title: Discovery of new quinazolin-4-ones as dual EGFR/c-SRC inhibitors with potential to overcome bypass-mediated resistance in cancer. Article Snippet: This study reports the rational design, synthesis, and preliminary evaluation of a novel series of quinazolin-4-one derivatives.. These compounds were developed as potential dual inhibitors of EGFR and c-SRC kinases to explore their utility in addressing bypass-related signaling in cancer cells.. Through systematic optimization, compound 9b emerged as a lead candidate, demonstrating potent and balanced enzymatic inhibition with IC50 values of 0.057 μM (EGFR) and 0.073 μM (c-SRC). Article Title: Inhibition of the oncogenic GTPase dynamin-related protein 1 (DRP1) by the FDA-approved drug fosaprepitant: In silico, biophysical, and in vitro characterization of its anti-myeloma activity. Article Snippet: Mitochondrial fission plays a crucial role in sustaining cellular homeostasis, and disturbances in this process have been linked to numerous pathological conditions, including cancer.. The central regulator of mitochondrial division is the large GTPase dynamin-related protein 1 (DRP1), whose enzymatic activity drives the constriction and separation of mitochondria.. Given its pivotal function, DRP1 has gained attention as a potential oncogenic target across several cancer types. Article Title: Design synthesis and evaluation of a novel 1,3,4-thiadiazole derivative as a potent anticancer and antibacterial agent supported by electronic property analysis and simulation studies. Article Snippet: |